PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kahn SE et al. – Rosiglitazone treatment was associated with durable reductions in CRP independent of changes in insulin sensitivity, HbA1c, and weight gain. CRP in the glyburide and metformin groups was positively associated with changes in weight, but this was not the case with rosiglitazone.


   

Today in Clinical Pharmacology...keeping you current

Pharmacological treatment of depression in patients with a primary brain tumour
Cochrane Reviews, 03/18/10

Pegloticase for chronic gout
Cochrane Reviews, 03/18/10

Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period
Cochrane Reviews, 03/18/10

Today in Endocrinology...keeping you current

Angiogenesis-inhibitors for metastatic thyroid cancer
Cochrane Reviews, 03/18/10

The economics of obesity
American Journal of Clinical Nutrition, 03/18/10

Reviewing statin therapy in diabetes - Towards the best practise
Primary Care Diabetes, 03/18/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address